Institutional members access full text with Ovid®

Share this article on:

Treatment of Superior Limbic Keratoconjunctivitis With a Large-Diameter Contact Lens and Botulium Toxin A

Kim, Jae Chan MD, PhD; Chun, Yeoun Sook MD, PhD; Chun, YS; Kim, JC

doi: 10.1097/ICO.0b013e3181967006
Clinical Science

Purpose: To evaluate the effect of a large-diameter (16-20 mm) hydrogel contact lens (CL) or an injection of Botulinum Toxin A to Riolan muscle for the treatment of superior limbic keratoconjunctivitis (SLK).

Methods: Eight eyes from 8 patients were fitted with large-diameter CL for 7 days. The clinical improvement and changes of fluorescein and rose bengal staining were examined on the day of diagnosis and 3, 7, 14, and 30 days after the CL was fitted. Three eyes showing symptoms of recurrence of SLK within 1 month after removal of the CL and 2 eyes with complications related to CL were treated with an injection of Botulinum Toxin A to pretarsal orbicularis muscle, Riolan. The changes of symptoms and vital stains were also evaluated on day 7 and 1, 2, 3, and 6 months after the injection.

Results: The mean age was 48 ± 13.5 years, and the group consisted of 6 females and 2 males. Dry eye syndrome and horizontal conjunctival corrugation were found in all 8 patients, superior conjunctivochalasis in 5 patients, and floppy eyelid syndrome in 2 patients. Complete resolution after more than 1 month with CL only was seen in 3 eyes (37.5%). Clinical symptoms improved in 4.62 days and vital staining in 10.75 days after fitting of the CL. Superficial punctuate keratopathy related to CL occurred in 3 eyes (37.5%). Five eyes (62.5%) that were treated with botulinum showed distinct improvement within 7 days after the injection, and the effect was maintained for 2-7 months.

Conclusions: The fitting of large-diameter CL can be considered for the treatment of acute severe symptoms of SLK for a short time. An injection of Botulinum toxin to the Riolan muscle can effectively and rapidly resolve the symptoms associated with SLK, and its effect of maintenance was a mean of 4 months.

From the Department of Ophthalmology, College of Medicine, Chung-Ang University, Yongsan Hospital, Yongsan-Gu, Seoul, Korea.

Received for publication May 27, 2008; revision received September 11, 2008; accepted November 22, 2008.

Supported by Chung-Ang University Research Grants in 2008.

Reprints: Jae Chan Kim, MD, PhD, Department of Ophthalmology, Chung-Ang University Yongsan Hospital, 65-207, Hangangro-3Ga, Yongsan-Gu, Seoul 140-757, Korea (e-mail: yschun100@hanmail.net).

Treatment of Superior Limbic Keratoconjunctivitis With a Large-Diameter Contact Lens and Botulium Toxin A: Erratum

In the article that appeared on pages 752-758 in volume 28, issue 7, the author's names and reprints information appeared incorrectly. The names should have appeared as: Yeoun Sook Chun, MD, PhD and Jae Chan Kim, MD, PhD. For reprints, please contact Jae Chan Kim, MD, PhD, Department of Ophthalmology, Chung-Ang University Yongsan Hospital 65-207, Hangangro-3Ga, Yongsan-Gu, Seoul 140-757, Korea (e-mail: jck50ey@kornet.net). The erratum is printed in the October 2009 issue.

REFERENCE

Chun YS, Kim JC. Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and botulium toxin a. Cornea. 2009;28:752-758.

Copyright © 2009 Wolters Kluwer Health, Inc. All rights reserved.